Sanuwave Health Inc. of Suwanee, GA at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Sanuwave Health Inc.

3360 Martin Farm Road, Suite 100, 30024 Suwanee, GA
United States of America

Telephone +1 615 8239907
Fax +1 678 5690881
lisa.sundstrom@sanuwave.com

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2017 hall map (Hall 16): stand D10-8

Fairground map

MEDICA 2017 fairground map: Hall 16

Our range of products

Product categories

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.07  Orthopaedic shock wave therapy equipment

Orthopaedic shock wave therapy equipment

Our products

Product category: Orthopaedic shock wave therapy equipment

dermaPACE

The dermaPACE device is currently available only to physicians and patients involved in an Investigational Device Exemption clinical trial. It is not for sale in the United States. The dermaPACE is CE Marked for select international markets for the treatment of chronic and acute conditions of the skin and subcutaneous tissue.

For more information on the trial please visit www.ClinicalTrials.gov.

More Less

Product category: Orthopaedic shock wave therapy equipment

orthoPACE

The orthoPACE is CE Marked for international markets for orthopedic and musculoskeletal indications, but is not currently approved for sale or distribution in the United States.

More Less

Product category: Orthopaedic shock wave therapy equipment

OssaTron

The OssaTron is the first and only Extracorporeal Shock Wave Technology (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopedic conditions which have failed to respond to conservative treatment.

More Less

About us

Company details

SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of a high- energy, focused, shock wave technology that is used in devices for the repair and regeneration of bones, muscles, tendons and skin, and for the separation of solids and fluid in non-medical systems.

Within healthcare, SANUWAVE’s proprietary, patented Pulsed Acoustic Cellular Expression (PACE) technology emits high-energy, acoustic shock waves that restore the body’s normal healing processes. This activates   biologic signaling which leads to tissue repair and regeneration and blood vessel growth – revascularization and microcirculatory enhancement.

SANUWAVE has three devices that employ the PACE technology.  The lead device for the global wound care market, dermaPACE®, is approved for use outside the United States (CE Marked) for advanced wound care indications and is currently being studied in a U.S-based supplemental pivotal clinical trial for diabetic foot ulcers.  The orthoPACE® device is CE Marked for orthopedic and musculoskeletal indications.  OssaTron®, the Company’s legacy device, is approved by the FDA for multiple orthopedic conditions which have failed to respond to conservative treatment.

In addition, SANUWAVE has patented the use of its shock wave technology in non-medical fields, including energy (improved/enhanced oil recovery), water (purification), food (bacterial reduction), and industrial effluent (particulate separation), and is working toward licensing/partnership relationships.

Headquartered in Alpharetta, Georgia, SANUWAVE designs, manufactures, markets, and services its industry leading products for worldwide distribution.

More Less